Drug Type Universal CAR-T |
Synonyms- |
Target |
Mechanism CD20 modulators(B-lymphocyte antigen CD20 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Phase 2 | CN | 01 Mar 2016 |